Varian Medical Systems announced today that the Food and Drug Administration has approved its BrachyVision 6.0 treatment planning software for marketing in the U.S.
The imaged-based tool is a comprehensive planning system for all brachytherapy treatments, according to the Palo Alto, CA-based company. It can be used to develop treatment plans for low or high dose-rate brachytherapy, including treatment of cancer in the head and neck, cervix, lung, prostate, and breast.
The 3-D color images generated by the BrachyVision software offer doctors a better perspective on tumors, surrounding anatomy, and the impact of various radiation doses, Varian said. Treatment plans can be generated in as little 10 minutes for straightforward cervical cases.
By AuntMinnie.com staff writersMay 10, 2000
Copyright © 2000 AuntMinnie.com
